Lipitor, Atorvastatin Newswire

Lipitor, Atorvastatin Newswire

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic).

Results 1 - 20 of 228 in Lipitor, Atorvastatin (generic)

  1. at the press club, kambraRead the original story w/Photo

    Yesterday | Your Democracy

    He is a member of the Republican Party. In 2012, He launched the Energy and Enterprise Initiative, a "nationwide public engagement campaign promoting conservative and free-enterprise solutions to energy and climate challenges".

    Comment?

  2. Esperion Provides Bempedoic Acid Development Program Update; Reports...Read the original story

    Yesterday | BioSpace

    Esperion Therapeutics, Inc. , the lipid management company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies for the treatment of patients with elevated low density lipoprotein cholesterol , today provided bempedoic acid development program updates and financial results for the fourth quarter and full year ended December 31, 2016. "Last year, Esperion was focused on building a strong foundation for the development and initiation of our global pivotal Phase 3 clinical development program for bempedoic acid, which the team successfully initiated, including the CLEAR Outcomes cardiovascular outcomes trial," said Tim M. Mayleben, president and chief executive officer of Esperion.

    Comment?

  3. Big dangers of mixing medicationRead the original story w/Photo

    Sunday Feb 19 | KRISTV.COM Corpus Christi

    Anytime you take more than one medication, or even mix it with certain foods, beverages, or over-the-counter medicines, you are at risk of a drug interaction. Most drug interactions are not serious, but because a few are, it is important to understand the possible outcome before you take your medications.

    Comment?

  4. MKSAP: 74-year-old woman with altered mental statusRead the original story w/Photo

    Saturday Feb 18 | Kevin, M.D.

    A 74-year-old woman is evaluated in the emergency department for several hours of altered mental status. She is from out-of-state and is visiting with relatives.

    Comment?

  5. Cryptic Loss of Consciousness in a 36-Year-Old WomanRead the original story

    Jul 1, 2015 | Circulation

    From the Department of Neurology and Cardiology, Heart and Brain Centre , Helsinki University Hospital and University of Helsinki, Finland; and Department of Neurology and Stroke Unit, University Hospitals of Cleveland/Case Medical Center, OH . From the Department of Neurology and Cardiology, Heart and Brain Centre , Helsinki University Hospital and University of Helsinki, Finland; and Department of Neurology and Stroke Unit, University Hospitals of Cleveland/Case Medical Center, OH .

    Comment?

  6. How to Image Cardiac AmyloidosisRead the original story

    May 1, 2014 | Circulation

    From the Noninvasive Cardiovascular Imaging Program, Division of Cardiology, Departments of Radiology and Medicine , Division of Nuclear Medicine and Molecular Imaging, Department of Radiology , and Cardiac Amyloidosis Program, Cardiovascular Division, Department of Medicine , Brigham and Women's Hospital, Harvard Medical School, Boston, MA. From the Noninvasive Cardiovascular Imaging Program, Division of Cardiology, Departments of Radiology and Medicine , Division of Nuclear Medicine and Molecular Imaging, Department of Radiology , and Cardiac Amyloidosis Program, Cardiovascular Division, Department of Medicine , Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

    Comment?

  7. Implications of Recent Clinical Trials for the National Cholesterol...Read the original story

    Jul 13, 2004 | Circulation

    The Adult Treatment Panel III of the National Cholesterol Education Program issued an evidence-based set of guidelines on cholesterol management in 2001. Since the publication of ATP III, 5 major clinical trials of statin therapy with clinical end points have been published.

    Comment?

  8. In Focus BlogPraluent to Stay on Market as PCSK9 Patent War Continues in CourtRead the original story w/Photo

    Friday Feb 10 | The American Journal of Managed Care

    Attorneys for Sanofi, a sponsor of Praluent, said the public interest in having more than one drug available in the PCSK9 class would be an important part of their claim. Praluent, the first drug approved in the cholesterol-fighting drug class called PCSK9 inhibitors, won't be pulled from the shelves while sponsors Sanofi and Regeneron battle in federal court over Amgen's patent claim for rival Repatha.

    Comment?

  9. Statins Can Cause Loss of MemoryRead the original story w/Photo

    Apr 6, 2016 | Genesee Valley Pennysaver

    DEAR DR. ROACH: I have been taking Lipitor for high cholesterol. Lately, my pharmacist said that all statins can cause memory loss.

    Comment?

  10. Amgen cholesterol drug succeeds in cutting serious heart problems: studyRead the original story w/Photo

    Thursday Feb 2 | Yahoo!

    Amgen Inc said its potent cholesterol fighter Repatha significantly reduced the risk of heart attacks, strokes and death in patients with heart disease, according to initial results of a large, eagerly-anticipated trial released on Thursday. The data should pave the way for greater acceptance by health insurers and pharmacy benefit managers, who have been rejecting about 75 percent of prescriptions written for the expensive medicine despite multiple appeals by physicians.

    Comment?

  11. Cholesterol Drug Cuts Serious Heart ProblemsRead the original story w/Photo

    Friday Feb 3 | News Max

    Amgen Inc said its potent cholesterol fighter Repatha significantly reduced the risk of heart attacks, strokes and death in patients with heart disease, according to initial results of a large, eagerly-anticipated trial released on Thursday. The data should pave the way for greater acceptance by health insurers and pharmacy benefit managers, who have been rejecting about 75 percent of prescriptions written for the expensive medicine despite multiple appeals by physicians.

    Comment?

  12. Amgen's Cholesterol-Lowering Drug Repatha Wows in Huge Heart StudyRead the original story

    Thursday Feb 2 | BioSpace

    Amgen Announces RepathaA Significantly Reduced The Risk Of Cardiovascular Events In FOURIER Outcomes Study - Landmark Repatha Cardiovascular Outcomes Study Meets Primary and Key Secondary Endpoint - Detailed Results to be Presented at ACC 66th Annual Scientific Session /PRNewswire/ -- Amgen today announced that the FOURIER trial evaluating whether RepathaA reduces the risk of cardiovascular events in patients with clinically evident atherosclerotic cardiovascular disease met its primary composite endpoint , non-fatal stroke, hospitalization for unstable angina or coronary revascularization) and the key secondary composite endpoint . No new safety issues were observed.

    Comment?

  13. Newer Cholesterol Drugs are Safe: StudyRead the original story w/Photo

    Tuesday Jan 31 | News Max

    A combination of drugs that drastically lowers "bad" cholesterol levels appears safe for heart patients, but whether it prevents heart attacks or strokes isn't yet known, researchers report. "It may be that people need very low cholesterol levels to get a benefit in terms of heart attacks and stroke reduction, but that remains to be determined," said lead researcher Dr. Jennifer Robinson.

    Comment?

  14. Astellas Reports the First Nine Months Financial Results of FY2016Read the original story

    Monday Jan 30 | Customer Interaction Solutions

    Astellas Pharma Inc. today announced financial results for three quarters of fiscal year 2016 ending March 31, 2017 . "We achieved many milestones including the acquisition of Ganymed Pharmaceuticals, a Germany-based pharma company, last December.

    Comment?

  15. Study Suggests Newer Cholesterol Drugs Are SafeRead the original story w/Photo

    Monday Jan 30 | MSN Healthy Living

    These twins weighed only 1 pound each when they were born four months early. To see more of their journey, check out their Instagram.

    Comment?

  16. Drs. Oz & Roizen: Shoulder pain can indicate many medical problemsRead the original story w/Photo

    Monday Jan 30 | Athens Banner-Herald

    I recently injured my rotator cuff while swimming. I'm 61 and in good health, but when I went to my doctor, he said he wants me to get an EKG as well as an MRI for my shoulder.

    Comment?

  17. KU Reseachers Find Statins May Hold Keys to Future Cancer TreatmentRead the original story

    Tuesday Jan 24 | Newswise

    Researchers at the University of Kansas Medical Center have found that high doses of drugs commonly used to fight high cholesterol can destroy a rogue protein produced by a damaged gene that is associated with nearly half of all human cancers. Tomoo Iwakuma, M.D., Ph.D., an associate professor in the Department of Cancer Biology, and his team have published the first research showing how the use of statins, such as Lipitor , Crestor and Mevacor , can shut down structurally mutated p53 proteins that can accelerate cancer progression, while not harming proteins produced by healthy p53 genes.

    Comment?

  18. 'Could aspirin be giving me nose bleeds at night?'Read the original story w/Photo

    Monday Jan 23 | Daily Mail

    I had a heart attack two years ago, then a triple bypass. I'm 82, play golf three times a week and feel fit. 1 comment

  19. Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein...Read the original story

    Jan 23, 2017 | Circulation

    From Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Australia ; School of Medicine and Pharmacology, University of Western Australia, Crawley ; Amgen Europe, Inc, Zug, Switzerland ; and Amgen Inc, Thousand Oaks, CA . From Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Australia ; School of Medicine and Pharmacology, University of Western Australia, Crawley ; Amgen Europe, Inc, Zug, Switzerland ; and Amgen Inc, Thousand Oaks, CA .

    Comment?

  20. Presidential Health Has Always Been a Well-Kept SecretRead the original story w/Photo

    Jan 19, 2017 | Slate Magazine

    President-elect Donald Trump is 70 years old, which makes him the oldest incoming president by a few months. What does this mean for his health? According to his private physician , Dr. Harold Bornstein, Trump has normal blood pressure and no extensive medical history.

    Comment?